Literature DB >> 8576163

Mutant and infectious prion proteins display common biochemical properties in cultured cells.

S Lehmann1, D A Harris.   

Abstract

Prion diseases are unusual neurodegenerative disorders that can be both infectious and inherited. Both forms are hypothesized to result from a posttranslational structural alteration in the cell surface glycoprotein PrPc (cellular isoform of the prion protein) that converts it into the protease-resistant isoform PrPSc (scrapie isoform of the prion protein). However, a direct comparison of molecular events underlying these two manifestations of prion diseases has not been possible, because there has been no cell culture model for the familial forms. We report here that when mutant prion proteins associated with three different inherited prion disorders of humans are expressed as their murine homologues in cultured Chinese hamster ovary cells, the proteins are protease-resistant and detergent-insoluble, two biochemical properties characteristic of infectious PrPSc. In addition, each mutant protein remains tightly associated with the plasma membrane after enzymatic cleavage of its glycosylphosphatidylinositol anchor, a property that we now show is also typical of infectious PrPSc. The cell culture system described here is the first in vitro model for familial prion diseases and provides compelling evidence that infectious and genetic cases share common molecular features.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8576163     DOI: 10.1074/jbc.271.3.1633

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain.

Authors:  S Capellari; P Parchi; C M Russo; J Sanford; M S Sy; P Gambetti; R B Petersen
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Amphotericin B inhibits the generation of the scrapie isoform of the prion protein in infected cultures.

Authors:  A Mangé; N Nishida; O Milhavet; H E McMahon; D Casanova; S Lehmann
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Octapeptide repeat insertions increase the rate of protease-resistant prion protein formation.

Authors:  Roger A Moore; Christian Herzog; John Errett; David A Kocisko; Kevin M Arnold; Stanley F Hayes; Suzette A Priola
Journal:  Protein Sci       Date:  2006-02-01       Impact factor: 6.725

4.  An N-terminal polybasic domain and cell surface localization are required for mutant prion protein toxicity.

Authors:  Isaac H Solomon; Natasha Khatri; Emiliano Biasini; Tania Massignan; James E Huettner; David A Harris
Journal:  J Biol Chem       Date:  2011-03-08       Impact factor: 5.157

5.  Chaperone-supervised conversion of prion protein to its protease-resistant form.

Authors:  S K DebBurman; G J Raymond; B Caughey; S Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

6.  Two mutant prion proteins expressed in cultured cells acquire biochemical properties reminiscent of the scrapie isoform.

Authors:  S Lehmann; D A Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

7.  Glycosaminoglycan sulphation affects the seeded misfolding of a mutant prion protein.

Authors:  Victoria A Lawson; Brooke Lumicisi; Jeremy Welton; Dorothy Machalek; Katrina Gouramanis; Helen M Klemm; James D Stewart; Colin L Masters; David E Hoke; Steven J Collins; Andrew F Hill
Journal:  PLoS One       Date:  2010-08-23       Impact factor: 3.240

8.  Prion infection of epithelial Rov cells is a polarized event.

Authors:  Sophie Paquet; Elifsu Sabuncu; Jean-Louis Delaunay; Hubert Laude; Didier Vilette
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

9.  Defective retrotranslocation causes loss of anti-Bax function in human familial prion protein mutants.

Authors:  Julie Jodoin; Stéphanie Laroche-Pierre; Cynthia G Goodyer; Andréa C LeBlanc
Journal:  J Neurosci       Date:  2007-05-09       Impact factor: 6.167

10.  Loss of anti-Bax function in Gerstmann-Sträussler-Scheinker syndrome-associated prion protein mutants.

Authors:  Julie Jodoin; Micheal Misiewicz; Priya Makhijani; Paresa N Giannopoulos; Jennifer Hammond; Cynthia G Goodyer; Andréa C LeBlanc
Journal:  PLoS One       Date:  2009-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.